2017 FDA drug approvals

被引：1

|

作者：

Mullard A.

机构：

来源：

Nature Reviews Drug Discovery | 2018年 / 17卷 / 2期

关键词：

D O I：

10.1038/nrd.2018.4

中图分类号：

学科分类号：

摘要：

[No abstract available]

引用

收藏

页码：81 / 85

页数：4

相关论文

共 50 条

[31] Erratum: 2010 FDA drug approvals
Asher Mullard
Nature Reviews Drug Discovery, 2011, 10 (3) : 237 - 237
[32] FDA approvals for the first 6 months of 2017
Mullard, Asher
NATURE REVIEWS DRUG DISCOVERY, 2017, 16 (08) : 519 - 519
[33] FDA approvals for the first 6 months of 2017
Asher Mullard
Nature Reviews Drug Discovery, 2017, 16 : 519 - 519
[34] The Pharmaceutical Industry in 2017. An Analysis of FDA Drug Approvals from the Perspective of Molecules
de la Torre, Beatriz G.
Albericio, Fernando
MOLECULES, 2018, 23 (03):
[35] FDA moves to speed cancer drug approvals
Reynolds, T
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1996, 88 (08) : 491 - 491
[36] 2017 in review: FDA approvals of new molecular entities
Kinch, Michael S.
Griesenauer, Rebekah H.
DRUG DISCOVERY TODAY, 2018, 23 (08) : 1469 - 1473
[37] FDA Reaches a Milestone in Generic Drug Approvals
Voelker, Rebecca
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2021, 326 (13): : 1247 - 1247
[38] 2007 FDA drug approvals: a year of flux
不详
NATURE REVIEWS DRUG DISCOVERY, 2008, 7 (02) : 107 - 109
[39] 2007 FDA drug approvals: a year of flux
Bethan Hughes
Nature Reviews Drug Discovery, 2008, 7 : 107 - 109
[40] US FDA oncology drug approvals in 2014
Wolford, Juliet E.
Tewari, Krishnansu S.
FUTURE ONCOLOGY, 2015, 11 (13) : 1931 - 1945

← 1 2 3 4 5 →